Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Ranbaxy loses 180-day exclusivity on generic version of AstraZeneca's Nexium
The American drug regulator has revoked Ranbaxy Laboratories' 180-day exclusivity for selling a low cost version of AstraZeneca's blockbuster heartburn ......
Healthcare
TPG picks around 25% in Manipal Health for $150M
Manipal Health Enterprises Ltd, the healthcare arm of Manipal Group, has raised $150 million (over Rs 900 crore) from TPG ......
Healthcare
Ipca hit by US FDA import alert for its Ratlam plant
Mumbai-based Ipca Laboratories Ltd, which manufactures active pharmaceutical ingredients (APIs) and finished dosage forms, has received an import alert from ......
Healthcare
Biocon plans IPO for IVFA-backed drug discovery services arm Syngene
Biocon Ltd is looking to offload up to 15 per cent in its research arm Syngene International, a firm in ......
Healthcare
Apollo Hospitals may tap PE firms for $250M expansion plan
Apollo Hospitals Enterprise Ltd, the country's top hospital firm, has said it may look to rope in private equity investors ......
Healthcare
Belgian firm Eubage keen to invest $17M in Dr Datsons' manufacturing plant
Belgium-headquartered Eubage Laboratory, a firm which develops, manufactures and markets a broad range of nutrients and nutritional supplements, will invest ......
Healthcare
Par Pharmaceutical buys Ethics Bio Lab for around $20M
NYSE-listed Par Pharmaceutical, Inc has acquired Ethics Bio Lab Pvt Ltd, a Chennai-based contract research organisation (CRO) in an all ......
Healthcare
Oncology chain HCG picks bankers for its IPO
Bangalore-based HealthCare Global Enterprises Ltd (HCG), one of the largest cancer treatment hospital chains in the country has picked two ......
Healthcare
MyDentist in talks to raise $8M in its Series C round of funding
Mumbai-based Total Dental Care Pvt Ltd, which runs dental care chain under the MyDentist brand, is looking to raise Rs ......
Healthcare
Strides Arcolab in pact with Gilead to make & distribute generic version of its HIV drug
Strides Arcolab Limited has entered into a licensing agreement with Gilead Sciences, under which Gilead has extended non-exclusive rights to ......









